These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

381 related items for PubMed ID: 3061831

  • 1. Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital.
    Löscher W, Nolting B, Hönack D.
    Eur J Pharmacol; 1988 Jul 26; 152(1-2):9-17. PubMed ID: 3061831
    [Abstract] [Full Text] [Related]

  • 2. Effects of the non-NMDA antagonists NBQX and the 2,3-benzodiazepine GYKI 52466 on different seizure types in mice: comparison with diazepam and interactions with flumazenil.
    Löscher W, Hönack D.
    Br J Pharmacol; 1994 Dec 26; 113(4):1349-57. PubMed ID: 7889291
    [Abstract] [Full Text] [Related]

  • 3. Classification of compounds for prevention of NMDLA-induced seizures/mortality, or maximal electroshock and pentylenetetrazol seizures in mice and antagonism of MK801 binding in vitro.
    Palmer GC, Harris EW, Ray R, Stagnitto ML, Schmiesing RJ.
    Arch Int Pharmacodyn Ther; 1992 Dec 26; 317():16-34. PubMed ID: 1456842
    [Abstract] [Full Text] [Related]

  • 4. The competitive NMDA antagonist, D-CPP-ene, potentiates the anticonvulsant activity of conventional antiepileptics against maximal electroshock-induced seizures in mice.
    Zarnowski T, Kleinrok Z, Turski WA, Czuczwar SJ.
    Neuropharmacology; 1994 May 26; 33(5):619-24. PubMed ID: 7936096
    [Abstract] [Full Text] [Related]

  • 5. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy.
    Klitgaard H, Matagne A, Gobert J, Wülfert E.
    Eur J Pharmacol; 1998 Jul 24; 353(2-3):191-206. PubMed ID: 9726649
    [Abstract] [Full Text] [Related]

  • 6. Anticonvulsant effect of flutamide on seizures induced by pentylenetetrazole: involvement of benzodiazepine receptors.
    Ahmadiani A, Mandgary A, Sayyah M.
    Epilepsia; 2003 May 24; 44(5):629-35. PubMed ID: 12752460
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine.
    Löscher W, Hönack D.
    J Pharmacol Exp Ther; 1991 Feb 24; 256(2):432-40. PubMed ID: 1671593
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Competitive NMDA-receptor antagonists, LY 235959 and LY 233053, enhance the protective efficacy of various antiepileptic drugs against maximal electroshock-induced seizures in mice.
    Borowicz KK, Gasior M, Kleinrok Z, Czuczwar SJ.
    Epilepsia; 1996 Jul 24; 37(7):618-24. PubMed ID: 8681893
    [Abstract] [Full Text] [Related]

  • 13. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
    Lehmann J, Schneider J, McPherson S, Murphy DE, Bernard P, Tsai C, Bennett DA, Pastor G, Steel DJ, Boehm C.
    J Pharmacol Exp Ther; 1987 Mar 24; 240(3):737-46. PubMed ID: 2882014
    [Abstract] [Full Text] [Related]

  • 14. Muscle relaxant and anticonvulsant activity of 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, a novel N-methyl-D-aspartate antagonist, in rodents.
    Turski L, Klockgether T, Sontag KH, Herrling PL, Watkins JC.
    Neurosci Lett; 1987 Jan 14; 73(2):143-8. PubMed ID: 3029636
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor.
    Tricklebank MD, Singh L, Oles RJ, Preston C, Iversen SD.
    Eur J Pharmacol; 1989 Aug 11; 167(1):127-35. PubMed ID: 2550253
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The NMDA-receptor antagonist, MK-801, suppresses limbic kindling and kindled seizures.
    Gilbert ME.
    Brain Res; 1988 Oct 25; 463(1):90-9. PubMed ID: 2848609
    [Abstract] [Full Text] [Related]

  • 19. Ralitoline: a reevaluation of anticonvulsant profile and determination of "active" plasma concentrations in comparison with prototype antiepileptic drugs in mice.
    Löscher W, von Hodenberg A, Nolting B, Fassbender CP, Taylor C.
    Epilepsia; 1991 Oct 25; 32(4):560-8. PubMed ID: 1868813
    [Abstract] [Full Text] [Related]

  • 20. The effects of doxapram, diazepam, phenobarbital and pentylenetetrazol on suprathreshold and threshold stimulations in amygdaloid kindled rats.
    Albertson TE, Stark LG, Joy RM.
    Neuropharmacology; 1983 Feb 25; 22(2):245-8. PubMed ID: 6835492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.